Corpus 1,283 assessed · 1,184 scored · 647 reproduced ≥75 · 173 flagged ·∅ 73.9/100

Publications 3 Datasets 392.5k Experiments 5.5k

Explore

Filters: Asia ✕ 1 ✕ whole-exome sequencing (wes) ✕ clear all

3 matching publication(s)

Publication	Journal	Year	Score	Verdict
Developing a thyroid cancer differentiation state classification system using deep residual networks and metabolic signature profiling. ⚑ PMID 40993300	NPJ Digit Med	2025	—	L1 No data access ⚑
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104). PMID 38897205	Cell Rep Med	2024	72	L1 72/100
Bacillus Calmette-Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer. ⚑ PMID 35311085	Front Oncol	2022	30	L1 30/100 ⚑

Developing a thyroid cancer differentiation state classification system using deep residual networks and metabolic signature profiling.⚑

PMID 40993300 · NPJ Digit Med · 2025

L1 No data access ⚑

Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).

PMID 38897205 · Cell Rep Med · 2024

L1 72/100

Bacillus Calmette-Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer.⚑

PMID 35311085 · Front Oncol · 2022

L1 30/100 ⚑